TIDMDPH

RNS Number : 6428M

Dechra Pharmaceuticals PLC

22 September 2021

22 September 2021

Dechra(R) Pharmaceuticals PLC

(Dechra or the Company)

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

Dechra Pharmaceuticals PLC announces that on 20 September 2021, the following PDMRs acquired ordinary shares of 1p each in the Company pursuant to awards granted to them on 26 October 2018 under the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP). The vesting of the awards was subject to the achievement of performance conditions which were satisfied to the extent that the awards vested at 73.8%. Ian Page and Tony Griffin sold sufficient of the shares they acquired in order to fund the resulting tax liability. In accordance with the Company's Directors' Remuneration Policy, the remaining shares must be retained for a period of two years from the date of vesting.

 
 Name            Capacity    Shares     Shares Sold  Sale Price     Total beneficial   Percentage 
                              acquired                per share      shareholding       of issued 
                                                                     following this     share capital 
                                                                     announcement 
 Ian Page        Director    34,071     16,062       GBP52.365113   358,021            0.331% 
 Tony Griffin    Director    10,659     5,346        GBP52.365113   33,463             0.031% 
 

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the UK Market Abuse Regulation.

Notification of Dealing Forms

 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                Ian Page 
     ----------------------------------  ---------------------------------------- 
 2.   Reason for the notification 
     ---------------------------------------------------------------------------- 
 a)   Position/status                     Director/PDMR 
     ----------------------------------  ---------------------------------------- 
 b)   Initial notification/               Initial Notification 
       amendment 
     ----------------------------------  ---------------------------------------- 
 3.   Details of the Issuer 
     ---------------------------------------------------------------------------- 
 a)   Name                                Dechra Pharmaceuticals PLC 
     ----------------------------------  ---------------------------------------- 
 b)   LEI code                            213800J4UVB5OWG8VX82 
     ----------------------------------  ---------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ---------------------------------------------------------------------------- 
 a)   Description of                      Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                           ISIN: GB0009633180 
       Identification 
       code 
     ----------------------------------  ---------------------------------------- 
 b)   Nature of the                       Acquisition of shares pursuant to the 
       transaction                         Company's Long Term Incentive Plan 
     ----------------------------------  ---------------------------------------- 
 c)   Price(s) and volumes(s)             Price(s)                Volume(s) 
                                           GBPNil Cost             34,071 
     ----------------------------------  ----------------------  ---------------- 
 d)        Aggregated information 
             *    Aggregate volume 
                                            N/A 
 
             *    Price 
     ----------------------------------  ---------------------------------------- 
 e)   Date of the transaction             2021.09.20 
     ----------------------------------  ---------------------------------------- 
 f)   Place of the transaction            Outside a trading venue 
     ----------------------------------  ---------------------------------------- 
 
 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                               Ian Page 
     ---------------------------------  ------------------------------------------ 
 2.   Reason for the notification 
     ----------------------------------------------------------------------------- 
 a)   Position/status                    Director/PDMR 
     ---------------------------------  ------------------------------------------ 
 b)   Initial notification/              Initial Notification 
       amendment 
     ---------------------------------  ------------------------------------------ 
 3.   Details of the Issuer 
     ----------------------------------------------------------------------------- 
 a)   Name                               Dechra Pharmaceuticals PLC 
     ---------------------------------  ------------------------------------------ 
 b)   LEI code                           213800J4UVB5OWG8VX82 
     ---------------------------------  ------------------------------------------ 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ----------------------------------------------------------------------------- 
 a)   Description of                     Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                          ISIN: GB0009633180 
       Identification 
       code 
     ---------------------------------  ------------------------------------------ 
 b)   Nature of the                      Partial sale of shares obtained under 
       transaction                        the Company's Long Term Incentive Plan 
                                          to satisfy tax liability 
     ---------------------------------  ------------------------------------------ 
 c)   Price(s) and volumes(s)            Price(s)                  Volume(s) 
                                          GBP52.365113              16,062 
     ---------------------------------  ------------------------  ---------------- 
 d)        Aggregated information 
             *    Aggregate volume         16,062 
 
                                           GBP52.365113 
             *    Price                    GBP841,088.45 
 
 
             *    Total 
     ---------------------------------  ------------------------------------------ 
 e)   Date of the transaction            2021.09.21 
     ---------------------------------  ------------------------------------------ 
 f)   Place of the transaction           London Stock Exchange 
     ---------------------------------  ------------------------------------------ 
 
 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                   Tony Griffin 
     -------------------------------------  ------------------------------------------- 
 2.   Reason for the notification 
     ---------------------------------------------------------------------------------- 
 a)   Position/status                        Director/PDMR 
     -------------------------------------  ------------------------------------------- 
 b)   Initial notification/                  Initial Notification 
       amendment 
     -------------------------------------  ------------------------------------------- 
 3.   Details of the Issuer 
     ---------------------------------------------------------------------------------- 
 a)   Name                                   Dechra Pharmaceuticals PLC 
     -------------------------------------  ------------------------------------------- 
 b)   LEI code                               213800J4UVB5OWG8VX82 
     -------------------------------------  ------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ---------------------------------------------------------------------------------- 
 a)   Description of                         Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                              ISIN: GB0009633180 
       Identification 
       code 
     -------------------------------------  ------------------------------------------- 
 b)   Nature of the                           Acquisition of shares pursuant to 
       transaction                             the Company's Long Term Incentive Plan 
     -------------------------------------  ------------------------------------------- 
 c)   Price(s) and volumes(s)                Price(s)              Volume(s) 
                                              GBPnil                10,659 
     -------------------------------------  --------------------  --------------------- 
 d)        Aggregated information 
             *    Aggregate volume 
                                               N/A 
 
             *    Price 
     -------------------------------------  ------------------------------------------- 
 e)   Date of the transaction                2021.09.20 
     -------------------------------------  ------------------------------------------- 
 f)   Place of the transaction               Outside a trading venue 
     -------------------------------------  ------------------------------------------- 
 
 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                               Tony Griffin 
     ---------------------------------  ------------------------------------------ 
 2.   Reason for the notification 
     ----------------------------------------------------------------------------- 
 a)   Position/status                    Director/PDMR 
     ---------------------------------  ------------------------------------------ 
 b)   Initial notification/              Initial Notification 
       amendment 
     ---------------------------------  ------------------------------------------ 
 3.   Details of the Issuer 
     ----------------------------------------------------------------------------- 
 a)   Name                               Dechra Pharmaceuticals PLC 
     ---------------------------------  ------------------------------------------ 
 b)   LEI code                           213800J4UVB5OWG8VX82 
     ---------------------------------  ------------------------------------------ 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ----------------------------------------------------------------------------- 
 a)   Description of                     Ordinary Shares of 1 pence each 
       the financial 
       instrument 
                                          ISIN: GB0009633180 
       Identification 
       code 
     ---------------------------------  ------------------------------------------ 
 b)   Nature of the                      Partial sale of shares obtained under 
       transaction                        the Company's Long Term Incentive Plan 
                                          to satisfy tax liability 
     ---------------------------------  ------------------------------------------ 
 c)   Price(s) and volumes(s)            Price(s)                  Volume(s) 
                                          GBP52.365113              5,346 
     ---------------------------------  ------------------------  ---------------- 
 d)        Aggregated information 
             *    Aggregate volume         5,346 
 
                                           GBP52.365113 
             *    Price                    GBP279,943.89 
 
 
             *    Total 
     ---------------------------------  ------------------------------------------ 
 e)   Date of the transaction            2021.09.21 
     ---------------------------------  ------------------------------------------ 
 f)   Place of the transaction           London Stock Exchange 
     ---------------------------------  ------------------------------------------ 
 

For further information, please contact:

Melanie Hall, Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBDGDCIUDDGBD

(END) Dow Jones Newswires

September 22, 2021 08:59 ET (12:59 GMT)

Grafico Azioni Dechra Pharmaceuticals (LSE:DPH)
Storico
Da Nov 2021 a Dic 2021 Clicca qui per i Grafici di Dechra Pharmaceuticals
Grafico Azioni Dechra Pharmaceuticals (LSE:DPH)
Storico
Da Dic 2020 a Dic 2021 Clicca qui per i Grafici di Dechra Pharmaceuticals